bioMérieux S.A. (BIM.PA) is in Healthcare, Diagnostics & Research, based in France, listed on Paris. Market cap 9.76B EUR. 52-week range 65.60 to 116.10 EUR. Trailing P/E 21.2. Data as of 2026-10-09.
bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction ...